Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

10 Feb 2026 - 13 Feb 2026
17 Apr 2026 - 21 Apr 2026

Rapid Agglutination Latex Test Developed for Diarrheagenic Pathogens

By LabMedica International staff writers
Posted on 08 Oct 2014
Enteropathogenic and enterohemorrhagic Escherichia coli (EPEC/EHEC) are human intestinal pathogens responsible for diarrhea in both developing and industrialized countries.

A rapid and simple assay for EPEC/EHEC detection has been developed using the EPEC/EHEC-secreted proteins EspA and EspB, which were chosen as target antigens since they are the major secreted proteins in both pathogens.

Bacteriologists at the Instituto Butantan (São Paulo, Brazil) analyzed 71 atypical EPEC (aEPEC), 31 typical EPEC (tEPEC), and 23 EHEC belonging to different serotypes characterized as locus of enterocyte effacement (LEE)-positive isolates. More...
The secreted proteins EspA and EspB were detected using an enzyme linked immunosorbent assay and the absorbance was measured at 492 nm in a Multiskan EX ELISA reader (Thermo Scientific; Waltham, MA, USA).

For rapid agglutination latex test (RALT), bacterial isolates were grown on Dulbecco’s modified Eagle’s medium (DMEM)-agar and the tests were done using latex sensitized with anti-EspB monoclonal antibody (MAb). The RALT was performed on a slide glass using 20 µL of bacterial lysate and 20 µL of latex beads coupled to anti-EspB (MAb), and checking for agglutination after five minutes of gentle mixing. The EspB secreted protein was defined as a biomarker and its corresponding monoclonal antibody as the tool for EPEC/EHEC diagnosis; the production of EspB was better in DMEM medium.

The indirect ELISA using anti-EspB MAb showed 90.4% sensitivity and 96.4%, specificity, indicating its possible use in routine diagnostic laboratories. However, this methodology requires specific laboratory instrumentation, making it difficult to be performed in low-income country settings. The RALT assay can be considered an alternative assay for diarrhea diagnosis in low-income countries since it achieved 97% sensitivity, 98% specificity and 97% efficiency. RALT assay has the sensitivity and specificity required for high-impact diagnosis of neglected diseases in the developing world.

The authors concluded that serotyping-based diagnosis is the only methodology available in limited-resources settings, employing either commercial or in-house antisera. The standardized RALT for detection of EPEC and EHEC will have a remarkable impact in the diagnosis of these pathotypes, as the established agglutination latex test is a simple, rapid and easy to perform test, which can be employed in less equipped laboratories in low-income countries. The study was published on September 25, 2014, in the Public Library of Science Neglected Tropical Diseases.

Related Links:

Instituto Butantan 
Thermo Scientific



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Alcohol Testing Device
Dräger Alcotest 7000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.